Science Exchange Topics :
Tackling inability to access immune activity in current in vivo models
Expanding and engaging NK cell populations
Feasibility of targeting NK cells with low persistence
Science Exchange Leader:
Katrina Bykova, Associate Director, Discovery Biology & Pharmacology, Xencor, Inc.
Science Exchange Panellists:
Volker Huppert, Chief Development Officer, Glycostem
Generated by meetings and positions 5.0 by Kai Garlipp WWW: Kai Garlipp, Frank S. Zollmann. 7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.